View our publications

Read publications from the Muhitch Lab.

Read the research

Determining immunogenic vulnerabilities in kidney cancer 

The goal of the Muhitch lab is to elucidate the molecular mechanisms that limit renal cell carcinoma patient responses to immunotherapy. 

Our translational studies concentrate on enhancing anti-tumor immunity through improved myeloid cell function and cytolytic T cell activity within renal cell carcinoma.  

Meet our team Follow on Twitter
Dr. Muhitch in a hallway

Research focus

T cell activity within kidney cancer patient tumors

See the science
Cell Slide

Publications

Check out the latest articles, abstracts, editorials, and more from the Muhitch lab.

Read the research
Muhitch Lab Team

People

Get to know the Muhitch lab’s principal investigator and research team.

Meet our team

In the news

Roswell Park Teams Draw More Than $34 Million in Grants Supporting New Research
A Cancer Innovation Engine: 10 Roswell Park Research Advances to Look for in 2021
Deep Look at Immune Cells in Patients’ Tumors Reveals Insights on Timing for Treatment Combinations
Surgery and High-Dose SBRT Radiation Can Be Combined to Treat Kidney Cancer, Roswell Park Researchers Show

Faculty affiliations

Department of Immunology
Tumor Immunology and Immunotherapy Research Program
Tumor Immunology PhD Track

Connect with the Muhitch Lab

Email: Jason.Muhitch@RoswellPark.org  
Twitter: https://twitter.com/JMuhitch   

Department of Immunology
Roswell Park Comprehensive Cancer Center 
Elm and Carlton Streets 
Buffalo, NY 14263